Talks

  1. Hu J-R. Translating the HF GDMT paradigm: Designing a digital platform for “CKD GDMT”. American Heart Association (AHA) Kidney in Cardiovascular Disease Council (KCVD) Webinar [Virtual]. May 20, 2024.
  2. Hu J-R. Building Digital Tools for Cardiovascular and Kidney Disease. UC, San Francisco Kidney Health Research Collaborative (KHRC), San Francisco, CA [Virtual]. May 6, 2024.
  3. Hu J-R. Designing Digital Tools to Improve Uptake of Cardiovascular Guidelines. Asian Pacific Society of Cardiology/Emirates Cardiac Society Congress, Dubai, United Arab Emirates. May 3, 2024.
  4. Hu J-R. An Educational Portal for Evidence-Based Decision Making in Cardiac Tamponade. Yale Echo Research Meeting, New Haven, CT. March 27 2024.
  5. Hu J-R. Building Digital Tools for Decision-Making in Cardiology. El Salvador National Institute of Health Cardiovascular Symposium, San Salvador, El Salvador [Virtual]. March 15 2024.
  6. Hu J-R. Building Digital Tools for Decision-Making in Cardiology. Yale Internal Medicine Grand Rounds, New Haven, CT. January 11 2024.
  7. Hu J-R. Building Digital Tools for Decision-Making in Cardiology. Yale Cardiology Grand Rounds, New Haven, CT. December 5 2023.
  8. Hu J-R. Stressing Wisely: Bringing Guidelines to the Point of Care. Yale Cardiology Imaging Conference, New Haven, CT, October 27 2023.
  9. Hu J-R. A Novel Tool for Troponin Consults. Yale Cardiology Fellows’ Didactics, New Haven, CT; 2023. October 4 2023.
  10. Hu J-R. A Novel Tool for Troponin Consults. Yale Cardiology Fellows’ Didactics, New Haven, CT. June 28, 2023.
  11. Hu J-R. A Novel Tool for Troponin Consults. Yale Cardiology Imaging Conference, New Haven, CT. June 16 2023.
  12. Hu J-R. One-Year Update: GDMT for Everyone. American Heart Association Council for Kidney in Cardiovascular Disease, SCILL Committee. May 25 2023.
  13. Hu J-R. Appropriate Use Criteria for Multimodality Stress Imaging: the Stressing Wisely Initiative. Yale Nuclear Cardiology Conference, New Haven, CT. May 15 2023.
  14. Hu J-R. Modeling clinical decision-making on the consult service: Guideline Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction. Yale Clinical and Translational Research Accelerator (CTRA), New Haven, CT; June 8 2022.
  15. Hu J-R. Identifying Toxins Associated with Uremic Symptoms in Advanced Chronic Kidney Disease. National Young Investigators Forum, National Kidney Foundation, [Virtual due to COVID-19 pandemic]; April 23, 2021.
  16. Hu J-R. Identifying Toxins Associated with Uremic Symptoms in Advanced Chronic Kidney Disease. Mid-Atlantic Young Investigators Forum, National Kidney Foundation, [Virtual due to COVID-19 pandemic]; 2021.
  17. Hu J-R. Cardiovascular Mortality in End Stage Kidney Disease: Meta-Analysis and Metabolomic Approaches. American College of Physicians (ACP), Tennessee Chapter Meeting, Nashville, TN; October 10 2019.
  18. Hu J-R. Methods for Exploring Uremic Symptoms in the MDRD Study. Renal Disease Research Interest Group (RDIG) seminar, Johns Hopkins University, Baltimore, MD; 2018.
  19. Hu J-R. Serum Metabolomics and Mortality in Chronic Kidney Disease. Division Clinical Conference, Division of Nephrology and Hypertension, Vanderbilt University, Nashville, TN; 2017.
  20. Hu J-R. Associations Between the Serum Metabolome and All-Cause Mortality in Chronic Kidney Disease. National Young Investigators Forum, National Kidney Foundation, Orlando, FL; April 18, 2017.
  21. Hu J-R. Associations Between the Serum Metabolome and All-Cause Mortality in Chronic Kidney Disease. Mid-Atlantic Young Investigators Forum, National Kidney Foundation, Baltimore, MD; 2017.
  22. Hu J-R. Metabolomics and Mortality in Chronic Kidney Disease. Renal Disease Research Interest Group (RDIG) seminar, Johns Hopkins University, Baltimore, MD; 2017.
  23. Hu J-R. Metabolomics and Mortality in the MDRD Study. Methods in Cardiovascular Epidemiology (MICE) seminar, Johns Hopkins University, Baltimore, MD; 2017.